Id |
Subject |
Object |
Predicate |
Lexical cue |
T75 |
6-7 |
IN |
denotes |
• |
T76 |
9-20 |
NNP |
denotes |
Tocilizumab |
T77 |
20-21 |
-COMMA- |
denotes |
, |
T78 |
22-24 |
DT |
denotes |
an |
T79 |
25-33 |
NN |
denotes |
anti-IL6 |
T80 |
33-34 |
-COMMA- |
denotes |
, |
T81 |
35-38 |
MD |
denotes |
can |
T82 |
39-45 |
VB |
denotes |
confer |
T83 |
46-53 |
NN |
denotes |
benefit |
T84 |
54-56 |
IN |
denotes |
in |
T85 |
57-65 |
NNS |
denotes |
patients |
T86 |
66-70 |
IN |
denotes |
with |
T87 |
71-79 |
NN |
denotes |
COVID-19 |
T88 |
80-83 |
CC |
denotes |
and |
T89 |
84-88 |
JJ |
denotes |
high |
T90 |
89-92 |
NN |
denotes |
IL6 |
T91 |
95-103 |
NN |
denotes |
Abstract |
T92 |
104-107 |
DT |
denotes |
The |
R69 |
T82 |
T75 |
arg1Of |
confer,• |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R73 |
T82 |
T80 |
arg1Of |
confer,"," |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
R75 |
T82 |
T81 |
arg2Of |
confer,can |
R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
R78 |
T82 |
T84 |
arg1Of |
confer,in |
R79 |
T85 |
T84 |
arg2Of |
patients,in |
R80 |
T85 |
T86 |
arg1Of |
patients,with |
R81 |
T88 |
T86 |
arg2Of |
and,with |
R82 |
T87 |
T88 |
arg1Of |
COVID-19,and |
R83 |
T90 |
T88 |
arg2Of |
IL6,and |
R84 |
T90 |
T89 |
arg1Of |
IL6,high |